Rosuvastatin Completed Phase 2 Trials for Obstructive Coronary Artery Disease / Coronary Artery Disease (CAD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01837823YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering